Literature DB >> 33398341

Dynamics and competition of CRISPR-Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing.

Ya-Wen Fu1, Xin-Yue Dai1, Wen-Tian Wang1, Zhi-Xue Yang1, Juan-Juan Zhao1, Jian-Ping Zhang1, Wei Wen1, Feng Zhang1, Kerby C Oberg2, Lei Zhang1,3,4, Tao Cheng1,5,6, Xiao-Bing Zhang1,7.   

Abstract

Investigations of CRISPR gene knockout editing profiles have contributed to enhanced precision of editing outcomes. However, for homology-directed repair (HDR) in particular, the editing dynamics and patterns in clinically relevant cells, such as human iPSCs and primary T cells, are poorly understood. Here, we explore the editing dynamics and DNA repair profiles after the delivery of Cas9-guide RNA ribonucleoprotein (RNP) with or without the adeno-associated virus serotype 6 (AAV6) as HDR donors in four cell types. We show that editing profiles have distinct differences among cell lines. We also reveal the kinetics of HDR mediated by the AAV6 donor template. Quantification of T50 (time to reach half of the maximum editing frequency) indicates that short indels (especially +A/T) occur faster than longer (>2 bp) deletions, while the kinetics of HDR falls between NHEJ (non-homologous end-joining) and MMEJ (microhomology-mediated end-joining). As such, AAV6-mediated HDR effectively outcompetes the longer MMEJ-mediated deletions but not NHEJ-mediated indels. Notably, a combination of small molecular compounds M3814 and Trichostatin A (TSA), which potently inhibits predominant NHEJ repairs, leads to a 3-fold increase in HDR efficiency.
© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Year:  2021        PMID: 33398341     DOI: 10.1093/nar/gkaa1251

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  20 in total

1.  High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails.

Authors:  Brian R Shy; Vivasvan S Vykunta; Alvin Ha; Alexis Talbot; Theodore L Roth; David N Nguyen; Wolfgang G Pfeifer; Yan Yi Chen; Franziska Blaeschke; Eric Shifrut; Shane Vedova; Murad R Mamedov; Jing-Yi Jing Chung; Hong Li; Ruby Yu; David Wu; Jeffrey Wolf; Thomas G Martin; Carlos E Castro; Lumeng Ye; Jonathan H Esensten; Justin Eyquem; Alexander Marson
Journal:  Nat Biotechnol       Date:  2022-08-25       Impact factor: 68.164

Review 2.  Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies.

Authors:  Kelsie L Becklin; Garrett M Draper; Rebecca A Madden; Mitchell G Kluesner; Tomoyuki Koga; Miller Huang; William A Weiss; Logan G Spector; David A Largaespada; Branden S Moriarity; Beau R Webber
Journal:  CRISPR J       Date:  2022-08

Review 3.  CRISPR/Cas9 is a powerful tool for precise genome editing of legume crops: a review.

Authors:  Adnan Rasheed; Aminah A Barqawi; Athar Mahmood; Muhammad Nawaz; Adnan Noor Shah; Daniyah H Bay; Maryam A Alahdal; Muhammad Umair Hassan; Sameer H Qari
Journal:  Mol Biol Rep       Date:  2022-05-18       Impact factor: 2.742

Review 4.  Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer's Disease.

Authors:  Yuqing Liu; Xin Cheng; Hongli Li; Shan Hui; Zheyu Zhang; Yang Xiao; Weijun Peng
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

Review 5.  Adeno-associated virus vector-mediated gene therapy for the treatment of ovarian cancer: a literature review.

Authors:  Jiaojiao Zhu; Tiansheng Qin; Linzhen Wei; Fan Chen; Yaoyao Ding; Qianqian Zhang; Yamei Dang
Journal:  Ann Transl Med       Date:  2022-09

6.  Effective control of large deletions after double-strand breaks by homology-directed repair and dsODN insertion.

Authors:  Wei Wen; Zi-Jun Quan; Si-Ang Li; Zhi-Xue Yang; Ya-Wen Fu; Feng Zhang; Guo-Hua Li; Mei Zhao; Meng-Di Yin; Jing Xu; Jian-Ping Zhang; Tao Cheng; Xiao-Bing Zhang
Journal:  Genome Biol       Date:  2021-08-20       Impact factor: 13.583

Review 7.  Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells.

Authors:  Byung-Chul Lee; Richard J Lozano; Cynthia E Dunbar
Journal:  Mol Ther       Date:  2021-09-10       Impact factor: 11.454

Review 8.  CRISPR-Based Genome Editing as a New Therapeutic Tool in Retinal Diseases.

Authors:  Seyed Ahmad Rasoulinejad; Faezeh Maroufi
Journal:  Mol Biotechnol       Date:  2021-05-31       Impact factor: 2.695

9.  Rapid characterization of adeno-associated virus (AAV) gene therapy vectors by mass photometry.

Authors:  Di Wu; Philsang Hwang; Tiansen Li; Grzegorz Piszczek
Journal:  Gene Ther       Date:  2022-01-20       Impact factor: 4.184

10.  Efficient biallelic knock-in in mouse embryonic stem cells by in vivo-linearization of donor and transient inhibition of DNA polymerase θ/DNA-PK.

Authors:  Daisuke Arai; Yoichi Nakao
Journal:  Sci Rep       Date:  2021-09-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.